Human Genome Epidemiology Literature Finder
|
Records 1 - 19 (of 19 Records) |
| Query Trace: Disease Progression and SF3B1[original query] |
|---|
| Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. Blood 2013 Jun 121 (24): 4902-5. Rossi Davide, Spina Valeria, Bomben Riccardo, Rasi Silvia, Dal-Bo Michele, Bruscaggin Alessio, Rossi Francesca Maria, Monti Sara, Degan Massimo, Ciardullo Carmela, Serra Roberto, Zucchetto Antonella, Nomdedeu Josep, Bulian Pietro, Grossi Alberto, Zaja Francesco, Pozzato Gabriele, Laurenti Luca, Efremov Dimitar G, Di-Raimondo Francesco, Marasca Roberto, Forconi Francesco, Del Poeta Giovanni, Gaidano Gianluca, Gattei Valt |
| SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution. American journal of hematology 2014 Aug 89 (8): E109-15. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Wu Shang-Ju, Liu Chieh-Yu, Chen Chien-Yuan, Tseng Mei-Hsuan, Huang Chi-Fei, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Hsu Szu-Chun, Ko Bor-Sheng, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome. Blood cancer journal 2014 4 e177. Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H |
| SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 2015 Jul 126 (2): 233-41. Malcovati Luca, Karimi Mohsen, Papaemmanuil Elli, Ambaglio Ilaria, Jädersten Martin, Jansson Monika, Elena Chiara, Gallì Anna, Walldin Gunilla, Della Porta Matteo G, Raaschou-Jensen Klas, Travaglino Erica, Kallenbach Klaus, Pietra Daniela, Ljungström Viktor, Conte Simona, Boveri Emanuela, Invernizzi Rosangela, Rosenquist Richard, Campbell Peter J, Cazzola Mario, Hellström Lindberg E |
| Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS). Leukemia research 2016 Oct 49 108-12. Berman Ellin, Jhanwar Suresh, Hedvat Cyrus, Arcila Maria E, Wahab Omar Abdel-, Levine Ross, Maloy Molly, Ma Wanlong, Albitar Mah |
| Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia. Oncotarget 2016 Jan . Hou Hsin-An, Liu Chieh-Yu, Kuo Yuan-Yeh, Chou Wen-Chien, Tsai Cheng-Hong, Lin Chien-Chin, Lin Liang-In, Tseng Mei-Hsuan, Chiang Ying-Chieh, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Li Chi-Cheng, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Chen Chien-Yuan, Lin Chien-Ting, Wu Shang-Ju, Tsay Woei, Tien Hwei-Fa |
| Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia. Leukemia 2018 7 33 (2): 390-402. Leeksma Alexander C, Taylor Justin, Wu Bian, Gardner Jeffrey R, He Jie, Nahas Michelle, Gonen Mithat, Alemayehu Wendimagegn G, Te Raa Doreen, Walther Tatjana, Hüllein Jennifer, Dietrich Sascha, Claus Rainer, de Boer Fransien, de Heer Koen, Dubois Julie, Dampmann Maria, Dürig Jan, van Oers Marinus H J, Geisler Christian H, Eldering Eric, Levine Ross L, Miller Vincent, Mughal Tariq, Lamanna Nicole, Frattini Mark G, Heaney Mark L, Zelenetz Andrew, Zenz Thorsten, Abdel-Wahab Omar, Kater Arnon |
| Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome. Clinical epigenetics 2018 4 10 42. Lin Ming-En, Hou Hsin-An, Tsai Cheng-Hong, Wu Shang-Ju, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Liu Ming-Chih, Liu Chia-Wen, Chou Wen-Chien, Chen Chien-Yuan, Tang Jih-Luh, Yao Ming, Li Chi-Cheng, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Lin Chien-Ting, Tien Hwei-Fa |
| Ring sideroblasts in chronic phase of polycythemia vera identifies a subset of patients with an increased risk of progression to blast phase. Annals of diagnostic pathology 2019 4 40 45-48. Hidalgo-Lopez Juliana E, Kanagal-Shamanna Rashmi, Reyes Steven, Zhao Chong, Medeiros L Jeffrey, Bueso-Ramos Carlos |
| The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib. Blood 2019 10 134 (23): 2107-2111. O'Sullivan Jennifer M, Hamblin Angela, Yap Christina, Fox Sonia, Boucher Rebecca, Panchal Anesh, Alimam Samah, Dreau Helene, Howard Kieran, Ware Pauline, Cross Nicholas C P, McMullin Mary Frances, Harrison Claire N, Mead Adam |
| Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome. Scientific reports 2020 10 10 (1): 18622. Wang Haiqiong, Guo Yongbo, Dong Zhenkun, Li Tao, Xie Xinsheng, Wan Dingming, Jiang Zhongxing, Yu Jifeng, Guo Ro |
| Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
| Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations. Clinical lymphoma, myeloma & leukemia 2021 11 22 (5): e293-e299. Polprasert Chantana, Niparuck Pimjai, Rattanathammethee Thanawat, Chuncharunee Suporn, Kobbuaklee Sirorat, Songserm Kritanan, Suksusut Amornchai, Trithiphen Sasinipa, Lanamtieng Theerin, Kongkiatkamon Sunisa, Chanswangphuwana Chantiya, Lawasut Panisinee, Bunworasate Udomsak, Rojnuckarin Ponlap |
| High erythroferrone expression in CD71 erythroid progenitors predicts superior survival in myelodysplastic syndromes. British journal of haematology 2021 1 192 (5): 879-891. Riabov Vladimir, Mossner Maximilian, Stöhr Alexandra, Jann Johann-Christoph, Streuer Alexander, Schmitt Nanni, Knaflic Antje, Nowak Verena, Weimer Nadine, Obländer Julia, Palme Iris, Schumann Christiane, Baldus Claudia D, Schulze Torsten J, Wuchter Patrick, Röhl Henning, Jawhar Ahmed, Weiss Christel, Boch Tobias, Metzgeroth Georgia, Neumann Martin, Hofmann Wolf-Karsten, Nolte Florian, Nowak Dani |
| Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis. Cancers 2022 5 14 (10): . González-López Oscar, Muñoz-González Javier I, Orfao Alberto, Álvarez-Twose Iván, García-Montero Andrés |
| Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS). Clinical lymphoma, myeloma & leukemia 2022 2 22 (7): e467-e476. Chan Onyee, Ali Najla Al, Sallman David, Padron Eric, Lancet Jeffrey, Komrokji Ra |
| The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression. Genes, chromosomes & cancer 2023 6 . David Cabrerizo Granados, Indira Barbosa, Panagiotis Baliakas, Eva Hellström-Lindberg, Vanessa Lund |
| Somatic Activating ESR1 Mutation in an Aggressive Prolactinoma. The Journal of clinical endocrinology and metabolism 2024 9 . Ticiana Paes, Jacobo Buelvas Mebarak, John C Magnotto, George A Stamatiades, Yanan Kuang, Cloud Paweletz, Edward R Laws, Natalie Grosek, Rona S Carroll, Rinath Jeselsohn, Dipika R Mohan, Antonio Marcondes Lerario, Minh T Truong, Wenya Linda Bi, David A Reardon, David M Meredith, Ursula B Kaiser, Ana Paula Abr |
| Impact of Driver Mutations on Metastasis-Free Survival in Uveal Melanoma: A Meta-Analysis. Cancers 2024 7 16 (14): . David Lamas-Francis, Carmen Antía Rodríguez-Fernández, Elia de Esteban-Maciñeira, Paula Silva-Rodríguez, María Pardo, Manuel Bande-Rodríguez, María José Blanco-Teijei |
- Page last reviewed:Feb 1, 2024
- Content source: